Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma. Bangladesh Journal of Pharmacology, [S. l.], v. 14, n. 1, p. 32–35, 2019. DOI: 10.3329/bjp.v14i1.38807. Disponível em: https://banglajol.info/index.php/BJP/article/view/38807. Acesso em: 1 jul. 2026.